Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
experimental therapy
Biotech
Shionogi licenses out 3rd-gen HIV asset to ViiV
Japanese pharma Shionogi has penned a new licensing deal for a long-acting HIV asset from ViiV.
Ben Adams
Sep 28, 2021 9:10am
Another death blights Astellas' $3B Audentes buy
Sep 14, 2021 3:45am
Adverum shares halved after trial patient goes blind in one eye
Apr 29, 2021 7:30am
How GeNeuro's experimental MS drug might help treat COVID-19
Apr 15, 2021 1:30am
Orphazyme shares sink as late-stage test flops
Mar 29, 2021 8:50am
Immunovant hits the pause button for eye drug
Feb 2, 2021 9:25am